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1. Introduction
1.1. General overview of insulin/IGF-signalling
The IIS cascades are initiated by binding of Insulin or Insulin-like growth factors (IGF-1 and
-2) to their receptors, the Insulin receptor (IR), and the two Insulin-like growth factor receptor
1 (IGF-1r) and 2 (IGF-2r) (Fig. 1). While high affinity binding occurs between the cognate
ligand-receptor pairs, each ligand binds to the other receptors with lower affinity [2]. IR, IGF-1r
and -2r are dimers that occur as homo- but also as heterodimers, the latter of which are studied
in various cancer cells [3]. Such hybrid receptors are also found in the central nervous system,
however a clear function for them has not emerged as yet [4] although activation of different
signalling cascades followed by a different biological effect is a likely scenario [2]. IR, IGF-1r
and -2r are tyrosine receptor kinases that phosphorylate themself as well as downstream
adaptor proteins like the insulin receptor substrate proteins (IRS-1-4) [5]. Through phosphor‐
ylation, IRS proteins bind to SRC-homology-2 (SH-2) domain-containing proteins like SRC,
SRC homology2-B (SH2-B), protein phosphatases like Tyrosine-protein phosphatase non-
receptor type 1 (PTPN1), or the p85 subunit of phosphatidyl inositol 3-kinase (PI3K).
Two major signalling pathways are activated through IIS: the PI3K- and/or the RAS/Mitogen-
activated protein kinase- (MAPK) pathways that are implicated in the regulation of a plethora
of different cellular processes.
PI3K belongs to a family of lipid kinases that are grouped into three classes. Class IA PI3K are
heterodimers of a p110 catalytic and a p85 or p55 regulatory subunit [6]. Binding of PI3K is
followed by activation of the p110 catalytic subunit of the kinase, which catalyses the increase
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of phosphatidylinositol-3,4,5-triphosphate (PtdIns{3,4,5}P3) lipids. PtdIns{3,4,5}P3 induce
phosphorylation of phosphoinositide-dependent protein kinase 1 (PDK-1), and the AGC
kinase AKT. In mammals, AKT has three different isoforms, AKT-1,-2, and -3. Each of them
has two critical sites in their activation domain, Thr308 and Ser473 that need to be phosphory‐
lated both to achieve full kinase activation. Inactive AKT is localised in the cytosol, but it is
recruited to the plasma membrane together with PDK-1 through association with phosphati‐
dylinositol-4,5- diphosphosphate (PtdIns{4,5}P2) and PtdIns{3,4,5}P3. As a result, PDK-1 and
AKT colocalise at the plasma membrane, which allows PDK-1 to induce phosphorylation of
AKT at Thr308. AKT phosphorylation at Ser473 occurs by integrin-linked kinase (ILK) as well
as mTORC-2 that are therefore PDK-2s for AKT [7]. Substrates of AKT are numerous, including
pro-apoptotic proteins like BAD or anti-apoptotic proteins like BCL-2, NF- κB, and MCL-1,
Forkheadbox transcription factors of the FOXO family as well as GSK-3β. AKT also phos‐
phorylates and inhibits the dimer tuberous sclerosis complex-1/-2 (TSC-1/TSC-2), which acts
as inhibitory GTPase-activating protein for RHEB. The GTPase RHEB can activate mTORC-1,
which has several substrates like p70 ribosomal protein S6 kinase (p70S6K), the translation
initiation regulator 4E binding protein (4E-BP), and the proline-rich AKT substrate PRAS40.
Through this signalling cascade, IIS activates mTORC-1 to promote cellular growth, transla‐
tion, transcription, and autophagy. mTORC-1 activation initiates a negative feed back loop
through active p70S6K that phosphorylates and inhibits IRS, thereby preventing activation of
PI3K in response to IIS. As indicated above, mTORC-2 also influences upstream IIS by
phosphorylating AKT as PDK-2 and is involved in spatial growth by regulating the actin
cytoskeleton. However, little is known about mTORC-2 activation through IIS. Recent data
suggest that mTORC-2 activation through IIS relies on a putative PI3K that is insensitive to
the negative feed back loop that controls activation of mTORC-1 [8].
IIS triggering the RAS/MAPK pathways can lead to activation of a subset of three downstream
kinases, ERK, JNK, and p38 [9] (Fig. 2). Activation of ERK is dependent on the RAS/MAPK
pathway, in which IIS results in phosphorylated IRS or SHC that recruit growth factor receptor-
bound protein 2 (GRB-2). GRB-2 associates with the protein son of sevenless (SOS), which is a
guanine nucleotide exchange factor. SOS acts by binding RAS-GTPase and forcing it to release
bound GDP and to bind GTP instead, which results in an activated state. Activated RAS
phosphorylates RAF, which in turn phosphorylates MEK that is responsible to activate the
MAPK ERK-1/-2. Jun aminoterminal kinases (JNK-1/-2) are further members of the MAPK
pathway that are as well activated through IIS. JNK activation is dependent on PI3K, whose
catalytic subunit does not bind to p85 but to the small RHO-family GTPase CDC42 [10]. This
complex activates MKK-4 (or MAP2K-4 (mitogen-activated protein kinase kinase 4), which
finally phosphorylates JNK-1/-2. The mechanism of p38 activation via IIS is so far unclear [9].
PI3K- and RAS/MAPK-pathways also converge on some downstream molecules like FOXO
proteins. Phosphorylation of FOXO through AKT leads to nuclear exclusion and interference
with target gene expression. Several other sites are phosphorylated through ERK and p38
MAPK. Interference with these posttranslational modifications leads to decreased promoter
binding together with ETS-1 transcription factor (TF) [11].
Trends in Cell Signaling Pathways in Neuronal Fate Decision38
2. Insulin/IGF-expression in the central nervous system
Insulin, Igf-1 and -2 as well as the three corresponding receptors are widely expressed in the
developing and mature central nervous system (CNS) (for a recent review refer to [1]).
Expression of Insulin and Igfs is in part under the control of Growth hormone (GH), but action
of several tissue- and developmental-specific transcription factors are also involved in Insulin/
Igf expression as is the nutritional status (our own unpublished observations and [12-14]).
Coordination and regulation of the biological activity of Igf-1 and -2, but not Insulin, is not
only achieved by transcriptional or translational control but also through a set of proteins that
have the ability to bind these ligands, namely the Igf-binding proteins (Igfbp). Upto date there
Figure 1. General overview of PI3K-dependent and mTor-driven IIS cascade and points of interference of serveral in‐
hibitors commony used to study downstream IIS.
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are several Igf-1 and -2 binding proteins as well as Igfbp-related (or -like) proteins that bind
to the ligands with varying affinities. Igfbps serve different functions, such as stabilisation and
regulation of the concentration of diffusible Igfs, as well as facilitating receptor binding and
modulation of Igf-bioavailability in the extracellular space [12]. Altogether, the various
subtypes of Igfbps bind 99% of circulating Igf-1 and -2. Within this fraction, 75% are bound to
Igfbp-3. Only 1% of Igf-1 and -2 is freely available in the extracellular space [15].
Igf-1 and -2 as well as the Igfbps are widely expressed in the brain [16,17]. Their expression
patterns have been described in multiple studies, mainly based on mRNA-detection methods
(summarised in [12]). Accordingly, Igf-1 is strongly expressed in the spinal cord, midbrain,
cerebral cortex, hippocampus and olfactory bulb (OB) during development. Igf-1 transcription
decreases postnatally as cell maturation advances to reach low levels in the adult central
nervous system. In the OB, Igf-1 expression persists at high levels in cells that are constantly
renewed even in the adult organism [18]. Igf-2 is also expressed in various brain regions and
also declines over development. However, it is considered to be the most abundantly expressed
Igf in the adult brain.
Igfbp-1 seems generally not to be present in sufficient amounts for detection in the central
nervous system [1,19]. Expression of Igfbp-2 is found over all gross neuroanatomical structures
of the rat brain, increasing from E15 until adulthood [20]. In preneurogenic stages (E10], rat
Igfbp-2 is strongly expressed in neuroectodermal structures of the neural tube and the
neuroepithelium [21]. In the postnatal brain it is mainly confined to astroglia as well as to the
Figure 2. General overview of IIS activating ERK in RAS/MAPK-dependent and JNK in CDC42-dependent manner.
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choroid plexus and leptomeninges [22]. Accordingly, IGFBP-2 is found closely associated with
human astroglial tumors. In this research field, it serves not only as a staging marker for
glioblastoma but is exploited for therapeutic intervention [23]. IGFBP-2 as well as bound IGF-2
are overexpressed in high-grade astrocytomas. MMP-9-mediated proteolysis of IGFBP-2 leads
to increased IGF-2 levels in these tumours. This accounts for increased aggressiveness of the
tumours through growth- and motility-promoting effects [24]. Expression of Igfbp-3 in the
brain is apparently not studied in great detail. However, Igfbp-3 expression increases after
brain insults and it has been shown to be upregulated in Alzheimer´s disease brains [25].
Igfbp-3 interacts with retinoic acid and might therefore also be implicated in cell differentiation
[26]. Igfbp-4 expression is also detected in most brain regions with declining levels over
development [20], being highly expressed in the hippocampus and cerebral cortex in adult
stages [27]. A function apart from regulation of Igf action has not been described yet. However,
Igfbp-4 expression is decreased in the cerebral cortex, hippocampus and the cerebellum in an
in vivo model for amyotrophic lateral sclerosis (ALS) [28]. Igfbp-5 is expressed mainly within
thalamic nuclei, leptomeninges and the perivascular sheaths in adult rats [27]. Igfbp-6 seems
to be expressed in differentiated but not in proliferating cells. Embryonic expression of Igfbp-6
in the CNS seems restricted to the trigeminal ganglia. Igfpb-6 transcription increases postna‐
tally after approx. 21 days in the forebrain and cerebellum, primarily in GABAergic inter‐
neurons. Higher levels are found in the hindbrain, spinal cord and dorsal root ganglia [29].
According to this strong association of Igfbp-6 expression with the cerebellar sensorimotor
system, overexpression of Igfbp-6 results in a reduced size of the cerebellum [30]. Igfbp-7 is
produced in the adult hippocampus, e.g. in the dentate gyrus (DG) [31]. In the postnatal
hippocampus, all components of the extracellular Insulin/Igf-signalling molecules were
detected apart from Igfbp-1. Variable amounts of individual components were detectable over
two developmental time points studied, as well as in different cellular sources, which comprise
neurons as well as glial and endothelial cells, albeit Igf-familiy member expression in the latter
two cell types were not studied in comprehensive detail.
In rodents, the Insulin-receptor (Ir) is expressed in the olfactory bulb (OB), cerebral cortex,
hippocampus, hypothalamus, pituitary, cerebellum, and the choroid plexus [32]. Expression
is high in early stages of development and declines in the adult, and is also more enriched in
neurons compared to glia. Within mature neurons, enrichment is observed within the
postsynaptic density [4,33]. Accordingly, Ir-signalling including downstream mediators like
Ras/MAPK and PI3K/Akt/mTor are implicated in synaptic connectivity and dendritic structure
[4]. Igf-1r has a similar expression pattern with high expression in the developing cerebellum,
midbrain, OB, and hindbrain [12]. However, although expression of Ir and Igf-1r is observed
in hippocampus, there are local differences in their distriubtion: Ir is enriched in the CA1 region
and Igf-1r is more prominent in the CA3 region. Levels of expression of the Igf-1r are higher
during development and decline to adult levels shortly after birth in the brain parenchyma,
while it stays relatively high in the choroid plexus, meninges and vascular sheaths.
Igf-2 receptor (Igf-2r) is also known as the mannose-6-phosphate (M6P) receptor, which has a
role in lysosomal enzyme trafficking. Accordingly, the main function described so far is to
internalise the Igf-2 ligand through endocytosis and to mediate degradation of Igf-2. However,
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recent studies reveal that Igf-2r is also implicated in specific signal transduction, e.g. in the
context of memory enhancement or fear extinction [13,31]. Igf-2r is also expressed in all major
neuroanatomical structures, with high expressions in the hippocampus, OB, retina, pituitary,
brain stem, and spinal chord. Further it is detected in the choroid plexus, ependymal as well
as endothelial cells [12].
Detailed analyses of expression of the upstream Igf-signalling members has been reported for
the mouse late embryonic and postnatal cerebellum [34]. Igf-1r is ubiquitously expressed,
whereas Igf-1 is detected in a subset of Purkinje cells (PC) at E17.5 and in postnatal stages. Igf-2
is confined to the meninges and blood vessels. Both ligands are not detectable in dividing
cerebellar granule precursor cells (CGP). Igfbp-1 is not detected, but Igfbp-2 is expressed wide
spread in the meninges, PC, internal as well as external granule layer, and choroid plexus.
Igfbp-3 is restricted to PC, Igfbp-4 to meninges and choroid plexus, and Igfbp-5 to Calbindin-
negative cells of the PC layer. Igfbp-6 is only detected in later stages in a subset of PC.
According to the widespread expression of members of the upstream IIS, their developmental
dynamics and cell type specificity, it is conceivable that this signalling pathway exerts
important function for development, maintenance as well as function of the various parts of
the central nervous system. Some of these functions that are mainly attributable to neuronal
development and fate decision will be highlighted in the following sections.
3. Biological effects associated with Insulin/IGF-signalling in neural
development
3.1. Insulin/IGF-signalling in ESC
Insulin and IGF are important factors to keep human ESCs in a proliferative state and to
promote  self-renewal,  where  upon  IGF-1R  has  been  identified  as  essential  component
[35].  Blocking of IGF-signalling results in differentiation, but it  is unclear whether a cer‐
tain  cell  fate  is  favoured  under  such  condition.  Downstream  signalling  of  Insulin  and
IGF has also been studied in this context and revealed that blocking of this pathway at
various points induced differentiation. In this study, blocking is achieved on the level of
PI3K through LY294002, of AKT-1, and of mTOR-1 through Rapamycin. Treatment of hu‐
man ESC with LY294002 results in loss of phosphorylation of the downstream molecules
AKT, p70S6K, S6 as well as GSK-3β [35-38].
Together with stromal cell-derived factor 1 (SDF-1/CXCL-12), pleiotrophin (PTN), and ephrin-
B1 (EFNB1) IGF-2 induces differentiation of human ESC into TH-positive dopaminergic
neurons [39].
Interestingly, retinol/vitamin A also induces Nanog transcription and the signal is transduced
over the IGF-1R, IRS-1, AKT and both mTOR complexes, mTORC-1 and mTORC-2 [40].
Expression of Nanog is a hallmark of proliferating, pluripotent stem cells. However, Insulin
has differentiating capacity into the neuroectodermal lineage when human ESCs are cocul‐
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tured with endodermal derived cells. This effect is dependent on PI3K/AKT signalling [41].
Together, these results reflect context-dependent IIS, and possibly cross-talk with other
signalling pathways activated e.g. in vivo through development or in vitro through cocultures.
3.2. Insulin/IGF effects in embryonic neural precursors
The Insulin-receptor (Ir) is expressed in distinct regions of the CNS, including the olfactory
bulb (OB), hypothalamus and the pituitary. Accordingly, a Nestin-cre mediated conditional,
CNS-specific knock-out of the Ir early during development results in increased Luteinising
hormone (LH) release from the hypothalamic-pituitary axis that leads to a deregulation of
energy homeostasis and endocrinology of the reproductive system [42].
Neurospheres generated from embryonic striatal precursors in the presence of Egf respond to
Igf-1 treatment with increased neuronal differentiation, presumably over an Igf-1r dependent
signalling cascade. However, this has not been addressed comprehensively through receptor
inhibition but was deduced from lower differentiation upon Igf-2 and Insulin stimuli
[16,17,43]. Igf-1 treatment in this setting is not accompanied by increased cell proliferation, but
cotreatment with Insulin increases the fraction of dividing cells. It might be that this effect is
specific to this combined treatment.
In the cerebral cortex, increased Igf-1 expression after Growth hormone (GH) treatment of rat
embryonal neural precursors is involved in increased proliferation of early (E14) and late (E17)
progenitors and is accompanied by increased neuronal differentiation at both time points. In
addition to neuronal differentiation, astrogenesis is also increased but only when late progen‐
itors are exposed to GH. This effect is also blocked in the presence of an Igf-1-blocking antibody
and thus illustrates that IIS is transducing GH-induced effects [42,44].
Increased proliferation of E14 rat cortical progenitor upon Igf-1 is observed in vitro after
treatment of cultured cells, and in vivo after intrauterine Igf-1 injection [45].
Igf-1 function in the brain is highly context-dependent and cell-type specific. This interpreta‐
tion is corroborated by the finding that Igf-1 treatment of E19 rat embryonal hippocampal
progenitors does influence survival of these cells [46].
In another setting, Igf-1 treatment evokes cell survival of mouse E10 neuroepithelial cells [47]
and it is mitogenic for sympathetic neuroblasts [48], showing that progenitor subtypes respond
differently to IIS. It is so far ill defined what kind of signalling events, including cross-talks to
other pathways, are associated with this differential outcome of Igf-1 stimulation. Interaction
with Egf- as well as Fgf-2-signalling and Igf-1 has been studied in striatal-derived neural
progenitor cells (NPCs). In this setting, highest numbers of formed spheres are obtained in the
presence of Igf-1 and Egf or Igf-1 and Fgf-2. Sphere formation in this context is highly de‐
pendent on presence of Igf-1, since no spheres were observed in the absence of IIS [49]. These
data show that Igf-1 is also affecting NPC proliferation in cooperation with other signalling
molecules, emphasising the pleiotrophic nature of IIS.
Igf-1-signalling seems to increase the effects of Fgf-2 on NPC proliferation as has been shown
in various stem cell populations, like rat adult SVZ neurospheres [50], neurospheres from
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mouse E13.5 forebrains [51], mouse embryonic OBSC [52], and mouse embryonic striatal NPC
[49]. Although not shown in all stem cells investigated so far, it is likely that in one scenario
Igf-1 promotes survival and proliferating competence of stem cells but that other mitogens
such as Erk-activators are needed to increase proliferation. However, other stem cell popula‐
tions might proliferate upon IIS without further mitogenic instructions as has been observed
by Fgf-2-independent Igf-1-mediated proliferation in rat embryonic NPCs from the cerebral
cortex and the hippocampus [45,46].
NPCs from neonatal rat forebrain undergo neuronal differentiation upon Insulin-treatment
[53]. The content of GFAP-positive cells in the neurosphere-based assay is unchanged, thus
suggesting a preference for neuronal differentiation in this cellular model.
Embryonal stem cells from the olfactory bulb (OBSC) are strongly dependent on IIS as shown
in vitro as well as in vivo. Igf-1 increases OBSC proliferation as well as differentiation without
strong lineage restriction, thus affecting neuronal as well as glial differentiation [54]. OBSC
proliferation however does not depend strictly on Igf-1, Insulin or pro-Insulin, they rather
potentiate the proliferating effect of Fgf-2 and Egf [52]. This study also showed that Igf-1
induces differentiation into the neuronal and astroglial lineages, but oligodendrocyte differ‐
entiation clearly depends on presence of other growth factors.
Several data support the finding that Igf-1 and -2 increase cerebellar granule cell precursor
(CGP) proliferation as well as survival of the same [34,55]. Different effects were linked to
different concentrations of the cytokine, where lower concentrations favoured survival and
higher proliferation [56]. IIS is supporting Sonic hedgehog (Shh) action that is a potent mitogen
for CGPs. Blocking of signal transduction through the Igf-1r diminishes Shh-mediated cell
proliferation, as well as endogenous supply of Igfbp-5. However, other Igfbps do not interfere
with Shh-mediated proliferation, but decrease Igf-1-dependent cell division [34].
Igf-2 treatment of CGP also results in proliferation. However it is unclear whether this occurs
over the Igf-1r or 2r [57] but it indicates also important function for Igf-2 in the context of
development of the central nervous system.
Igf-1 prevents cell death in primary rat embryonic hippocampal cultures after exposure to
glucocorticoids. While increased levels of corticosterone reduce Akt-phosphorylation and lead
to cell death, Igf-1 rescues cells from dying by increasing pAkt-levels in a PI3K-dependent
manner [58]. The same effect is observed by applying Insulin instead of Igf-1 [59].
Signalling of Insulin/Igf affects NPC proliferation, survival as well as differentiation in vitro
and this finding is corroborated in vivo by studies of knock-out and transgenic mouse models.
Transgene-mediated overexpression of Igf-1, driven by the Nestin-promoter, supports in
vitro finding that Igf-1 influences NPC proliferation as well as neuronal differentiation during
development. Cumulative BrdU-labelling shows that Igf-1 decreases the total length of the cell
cycle through acceleration of the G1-phase. This higher proliferating activity is paired with a
higher rate of cell-cycle re-entry. The overall increased number of progenitors provides a larger
pool of NPCs for neuronal differentiation and thus increases numbers of neurons residing in
the postnatal cortical plate of Igf-1-overexpressing mice [60]. In vivo, Igf-1 also exhibits survival
function since apoptosis is reduced upon its overexpression [61,62] which further contributes
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to increased numbers of neurons in the cortical plate. Igf-1 signalling does not affect all
neuronal populations in a similar manner but shows regional differences. The neuronal
composition of the motor cortex is more increased than the somatosensory cortex of Igf-1-
overexpressing mice, which is however also increased compared to wildtype animals. Neurons
in the cortical plate are also differently affected. Layer 1 neurons comprise the most increased
neuronal fraction in Igf-1-transgenic brains, layer 6 neurons show the smallest increase [63]. It
is thus likely that NPC are more sensitive to IIS during early developmental events of the
cerebral cortex in which neurogenesis of frontal precedes that of caudal regions and layer 1 is
preceding generation of layer 6.
In line with in vivo overexpression studies, complete loss of Igf-1 in mice leads to the opposite
effect of decreased numbers of specific neuronal populations in the cerebral cortex, e.g.
hippocampal granule cells and striatal parvalbumin-positive interneurons. Dopaminergic
neurons of the midbrain, basal forebrain cholinergic neurons, as well as motoneurons in the
spinal cord do not depend on Igf-1 presence [64]. Further analysis of this Igf-1-deficient mouse
revealed Igf-1-dependence of axonal growth and myelination that are strongly impaired.
Overall, Igf-1-deficient mice have a decreased number of myelinated axons. This observation
goes in line with studies of human IGF-I overexpression driven by a mouse metallothionein
promoter, that revealed increased myelin production by an unchanged number of oligoden‐
drocytes in adult brains [65].
Overexpression of Igf-1 driven by the Igf-2 promoter results in general brain overgrowth. The
greatest effect is seen in the cerebellum, although Igf-1 deletion does not lead to an observable
phenotype in this part of the brain, maybe because of compensatory effects from Igf-2 [55,64].
Igf-1r-deficient mice show severe growth retardation and die perinatally. Nestin-cre-mediated
conditional knockout of the Igf-1r also results in death shortly after birth but few animals
survive up to adulthood [66]. Mice that are heterozygote for the conditional Igf-1r deletion
also display severe growth retardation that was studied in detail in the hippocampus. In the
postnatal hippocampus all different parts are affected by increased rates of apoptosis rather
than by an impaired ability to proliferate through loss of the Igf-1r.
Mutations of the type 2 Igf receptor are lethal but are rescued from this perinatal lethality in
Igf-2 and Igf-1r null backgrounds [67]. This observation is attributed to increased Igf-2
signalling due to lack of internalisation of Igf-2, which is thought to be a major function of the
Igf-2r. Although general hyperplasia is observed including the brain, Igf-2r-signalling was not
further investigated in the brain [67-69].
Deletion of Igf-2 in mice results in severe growth-deficiency, but it was reported that Igf-2-
deficient mice do not show striking morphological aberrations [70,71]. However, one source
of Igf-2 during development is the choroid plexus, from which it is released into the cerebro‐
spinal fluid (CSF), and CSF-derived Igf-2 is an important signal for cell proliferation of later
embryonic precursors that have contact to the ventricular surface [72]. Progenitors of the SVZ,
e.g. Tbr-2-expressing cells, do not have contact to the CSF and thus are not influenced by Igf-2-
signalling in their proliferation capacity. Increased proliferation of cortical progenitors is
dependent on the apical (ventricular) localisation of the Igf-1r that is mediated through the cell
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polarity protein Pals-1 (Protein Associated with Lin Seven 1) as part of the apical complex.
Further support for an Igf-1r-mediated effect of Igf-2-signalling in this context comes from the
finding that loss of Pten (Phosphatase and Tensin homolog) opposes the effect of Pals-1-
deficiency: Pten-deficient mice have hyperplasic cortices while Pals-1-deficiency results in
cortical hypoplasia. The phenotypes are partially reverted through combination of both
transgenes [72]. Further downstream signals apart from Igf-1r and PI3K are not analysed in
this context.
The function of different Igfbps has been studied through transgenic mouse models. Thereby
it turned out, that loss of function mutations do not result in gross morphological changes
within the CNS. However, overexpression of Igfbps lead to phenotypes in the CNS, which are
exploited to achieve better understanding of IIS within this organ. Overexpression of Igfbp-1
in transgenic mice using either a phosphogylcerate kinase [73] or a methallothionein [74]
promoter results in similar phenotypes as observed in adult Igf-1-deficient mice: reduced brain
sizes due to loss of mature neurons and decreased progenitor proliferation, impaired myeli‐
nation as well as decreased activation of GFAP-expressing astrocytes in conditions of injury.
However, Igfbp-1 is normally not expressed at detectable levels in the CNS and the observed
findings are therefore attributed to the lack of Igf-1 as consequence of increased presence of
Igfbp-1. Most of the phenotypes observed in mice overexpressing Igfbps resemble those of loss
of Igf-1-signalling, which is mainly characterised by reduced organ size. Whether these
phenotypes are exclusively caused by impaired Igf-1-signalling or whether Igfbps have also
distinct functions, is so far not resolved [75]. Generally, Igfbp-5 is considered to potentiate
Igf-1-signalling, while Igfbp-2 mainly opposes Igf-1 and Igf-2 action [55]. This finding indicates
that some Igfbps might exert additional functions that might only be apparent in transgenic
mice in which the ligands are mutated as well.
3.3. Insulin/IGF effects in adult neural precursors
Igf-1, though not produced in high amounts in adult rodent brains, is required for normal
neuronal functions throughout life. As different source, peripheral Igf-1 is transported to
neuronal cells through an uptake from the blood stream (reviewed in [1]). Neural stem cells
of the adult hippocampus respond to peripheral administered Igf-1 with increased prolifera‐
tion as well as neurogenesis but not with astrogenesis [76]. These data were also confirmed in
vitro using neurospheres generated from the hippocampal dentate gyrus. In this setting, low
doses of Igf-1 mediate, and high doses interfere with neuronal differentiation [77]. Igf-1-
mediated cell proliferation of adult neuronal progenitor from the hippocampal subgranular
zone (SGZ) was also shown in a model of epilepsy [78] as well as in response to physical
excercise [79].
Further in vivo evidence for importance of Igf-1-signalling in the adult hippocampus comes
from a study of Igf-1-deficient rats. In this context Igf-1 supports survival of newly generated
neurons and possibly the maturation of the neuronal phenotype. However, cell proliferation
is not affected in this in vivo model [80]. Igf-1-instructed differentiation mainly into the
oligodendroglial lineage has been shown in rat adult hippocampal NPC [81] (Fig. 3). In this
study, withdrawal of proliferation-promoting Fgf-2 is essential to drive NPCs into differen‐
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tiation upon Igf-1. IIS in this setting induces expression of Bmp-antagonists Noggin and
Smad6, which are involved in the inhibition of an astrocytic cell fate and in favouring neuronal,
but more efficiently oligodendroglial differentiation. Further, this study showed again that
Igf-1 has a major impact on cell survival of adult NPCs.
Overexpression of Igf-1 through an Igf-2 promoter element results in increased numbers of
neurons in the postnatal mouse hippocampal dentate gyrus. This increase in neurogenesis is
transiently accompanied by increased numbers of synapses, which makes it possible that IIS
also influences synaptogenesis [82].
Adult rat NPC derived from the subventricular zone proliferate stronger upon an Igf-1
stimulus. This effect is blocked by the presence of Igfbp-3 that also decreases phosphorylation
of Akt [83]. Igf-1 signalling under Fgf-2-free conditions in adult subventricular stem cells is
also linked to differentiation [84]. Adult mouse NPC are initially cultivated in the presence of
Fgf-2. Subsequent withdrawal of Fgf-2 results in neuronal differentiation that is increased by
complementation with Igf-1. Blocking of the Igf-1 signal with an antibody reverts the effect
[85]. In this setting, the authors also explored the capacity of Igfbp-2 to influence the neurogenic
potential of the NPC, since Igfbp-2 complexes with Igf-1 and proteoglycans like heparin in the
rat OB [86]. Low doses of exogenous Igfbp-2 increase neuronal differentiation, while applica‐
tion of a blocking Igfbp-2 antibody interferes with this effect. These experiments indicate that
Igfbp-2 does not act by sequestering Igf-1 and by limiting its bioavailability, in which scenario
Igfbp-2 would have an opposing effect to Igf-1. Instead, both molecules exert the same
phenotypic differentiation and this indicates that Igfbp-2 function in this context is more likely
a protection of Igf-1 from degradation. It is conceivable that simultaneous interaction of Igfbp-2
Figure 3. Igf-1 signalling in adult rat hippocampal neurospheres [81].
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with proteoglycans decreases its affinity to Igf-1. The net outcome might be a locally increased
amount of free Igf-1 that drives neuronal differentiation of NPC [85]. In another study,
differentiation of SVZ NPC was deduced from reduced expression of the stem cell marker
Nestin after Igf-1 treatment, but it was not specified whether differentiation of a specific cell
lineage was favoured [50].
Further studies in adult mice show that lack of Igf-1 results in disturbed neuroblast exit from
the subventricular zone and their subsequent migration to the olfactory bulb through the
rostral migratory stream. This Igf-1 function is dependent on PI3-kinase activity and Disa‐
bled-1 (Dab-1) phosphorylation via Src-family kinase [87].
Igf-2 is not only provided from the CSF and important for early development of the brain. In
addition, adult mouse hippocampal stem cells from the DG also produce Igf-2, and to a much
lesser extend Igf-2 is also detected in adult SVZ-derived stem cells [19,88]. Challenging Igf-2
expression through siRNA-mediated approaches as well as treatment of DG-derived NPCs
reveals that Igf-2 also influences proliferation. However, SVZ-derived NPCs do not respond
with changed proliferation upon Igf-2 knockdown [88]. Igf-2 but not Igf-1 is involved in
neuronal survival of newly generated neurons in the adult DG in a model of fear extinction,
that is strongly associated with neurogenesis in the hippocampus [31]. Neuronal survival and
fear extinction depend on Igf-1r activity and are opposed by increased levels of Igfbp-7.
However, Igf-1 does not exert any observable effect in this setting.
FoxO proteins are under the control of IIS and therefore a downstream read-out of this
important signalling pathway. GFAP-cre was used to generate a triple allelic knockout of
FoxO1, 3, and 4 in adult NPCs. The observed effect on cell proliferation is dependent on the
age of the animal or passage of cells in culture. NPCs from young (P8) brains displayed
hyperproliferation upon loss of FoxO-proteins and the same was observed for early passages
of NPCs in culture. This initial hyperproliferation is followed by decreased doubling times
and the depleted progenitor pool results in declining neuronal differentiation. FoxOs balance
NPC proliferation and prevent premature loss of NPCs. Microarray studies revealed several
cell-cycle regulating genes that are affected in their expression by the loss of FoxO. Further‐
more, Aspm (asp (abnormal spindle)-like, microcephaly associated) and anatgonists of the
Wnt-signalling cascade, Sfrp-1 (secreted frizzled-related protein) and -2, as well as Sost
(sclerostin), are involved in the FoxO-dependent regulation. In this context FoxO might control
Wnt-induced cell proliferation by expression of Wnt-antagonists [89].
3.4. Insulin/IGF effects in mature neurons
Igf-1 applied to postnatal cerebellar granule neurons (CGN) prevents cell death, thus es‐
tablishing IIS  as  survival  factor  in mature neurons [90].  Another study described a link
of Igf-1-signalling in mature neurons to survival  of  CGN as well  as of  cortical  neurons.
Here, Igf-1 prevents apoptosis through activation of PI3K/Akt, but also through Igf-1r-de‐
pendend transactivation of unliganded Pac-1r (PACAP type 1 receptor) via Src-kinase ac‐
tivity [91] (Fig. 4).
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Figure 4. IIS mediated sur-vival of cortical neurons through activation of Akt and PAC-1r [91].
Data from adult Igf-1-deficient mice show however that cerebellar neurons are not affected by
the loss of this trophic factor in vivo [64]. Contrasting this finding is data showing overexpres‐
sion of human IGF-1 in mouse through a transgene driven by the mouse Igf-2 promoter [92]
that results in cerebellar overgrowth through blockage of the ontogenetic cell death that
normally takes place during early postnatal cerebellar development.
Blocking Igf-1 uptake through systemic application of an Igf-1 antibody not only reduces cell
proliferation in the adult rat and mouse hippocampus, but is also implicated in synaptic
remodelling and interferes with exercise-induced increase of dendritic spines [93]. IIS is also
implicated in neuronal maturation and stimulates neurite outgrowth. In postnatal rat slice
cultures of the somatosensory cortex, Igf-1-treatment leads to increased apical and basic
dendritic branching of pyramidal neurons [94]. As such, Igf-1 is involved in forming mature
neuronal networks and ensuring proper information processing. Further data show that Igf-1
mediates axonal growth by inducing plasmalemmal expansions by incorporation of vesicles
in the growth cone [95]. This Igf-1-, but not Insulin-dependent effect is mediated by signalling
via a growth-cone-specific Igf-1 receptor (βgc), Irs-2, Shp-2, PI3K and Akt. This cascade might
also influence dynamics of the cytoskeleton, namely microtubules and actin, both of which are
required for axonal growth.
Igf-2 has recently been shown to control the number of synaptic connections and plasticity in
mature neurons of the hippocampus [13,14]. Memory enhancement is specifically associated
with Igf-2 function. In this context Igf-2 is regulated by CCAAT enhancer binding protein β
(C/EBP) in adult rat hippocampus. C/EBP is one of the transcription factors necessary for
memory consolidation. In the study of Chen et al. rats are exposed to increased Igf-2 levels in
the hippocampus during memory training which results in improved learning [13]. This effect
is specific to Igf-2, since injection of Igf-1 did not have any observable effect in this memory
consolidation paradigm.
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Taken together, IIS has different effects in the developing and mature CNS that vary among
the different cell types as summarised in Fig. 5. Differences might be mediated through specific
downstream cascades or effector molecules present in only one specific cell or at a specific
developmental time point. Another scenario is the cross-talk between IIS and other cytokines
that are produced by the organism. Posttranslational modification of the receptors might be
another general mechanism that specifies different biological responses to common signal
inducers (ligand/receptor) and common intracellular signal transducers. The IGF-1r is
sumoylated and modulated in its activity. Sehat et al. showed [96] this sumoylation of the IGF-1
receptor that leads to internalisation of the ligand bound protein complex, which is transduced
to the nucleus and binds directly to genomic DNA. Since binding occurs predominantly in
intergenic regions, the biological relevance for differential gene transcription has still to be
shown. But nevertheless this reflects a possible mechanism through which specificity in
activation of different target genes upon the same stimulus might be obtained in different cells
or in the same cells at different developmental time points.
Figure 5. Differences in IIS function in different cell types of the CNS and in developmentThe Insulin-Igf Signalling (IIS)
pathway has multiple effects on different cells of the CNS. The effects, beginning from cues for ESC proliferation and
self-renewal, transcend to those of proliferation, self-renewal, differentiation and fate determination of NPCs. IIS con‐
tributes to either formation of neurons, or glia, oligodendrocytes and myelin.
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4. Insulin/IGF-signalling networks
4.1. Signalling networks in neural progenitors and neurons
Igf-1-dependent embryonal NPC proliferation in rat has been shown to be dependent on the
PI3K/Akt pathway, but not on the MAPK/Erk branch of signalling. Chemical inhibitors of the
latter, U0129 and PD98059, have no effect on NPC proliferation, while PI3K-inhibition through
LY294002 interferes with Akt- and downstream Gsk-3β-phosphorylation as well as prolifera‐
tion. Phosphorylated and thus inactivated Gsk-3β leads to stabilisation of CycD1 (Cyclin D1).
Together with increased expression of CycD3, and CycE as cell cycle promoters, decreased
expression of inhibitory cell cycle proteins p27 and p57 is observed upon Igf-1-treatment and
accounts for the mitogenic effect of Igf-1 [45] (Fig. 6).
Figure 6. Igf-1-dependent embryonal NPC proliferation in rat [45].
Cortical progenitors isolated from mouse E13.5 brains were investigated with regard to
increased Akt-1-signalling. Overexpression of Akt-1 results in increased proliferation as well
as survival of progenitors in vivo and in vitro, consistant with effects of increased IIS. This Akt-1
function does not depend on its action upon p21, but at least in part of mTorc-1, because
proliferation is partially hampered through Rapamycin. Survival is not affected through
mTorc1 inhibition [97]. Differential downstream signalling of Akt in cortical progenitors is
indicated by this study, which also reports that Rapamycin does only block proliferation in a
subset of cells at E13.5, and progenitors of later developmental stages are also insensitive to
Rapamycin with regard to proliferation (Fig. 7).
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Figure 8. Insulin-dependent neuronal differentiation of embryonic neurosheres [50].
Figure 7. Survival and proliferation upon Igf-1 treat-ment in mouse E13.5 cortical cells [97].
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MTorc-1 inhibition through Rapamycin prevents neuronal differentiation of rat embryonic
telencephalon-derived neurospheres that is observed in response to Insulin-signalling [53]. In
this setting, Insulin-treatment results in phosporylation of mTorSer2448 and of pS670K, and
the former is blocked through addition of Rapamycin, indicating that mTorc-1 is implicated
in neuronal differentiation. Apoptosis is not observed under these conditions (Fig. 8).
MTor-1-dependent neuronal differentiation is also observed in P19 embryonic carcinoma cells
that express Pax-6 as well as Hes-5 upon retinoic acid treatment and initiation of neural
differentiation. In this setting, Cdc42 is placed as upstream regulator of mTorc-1, and treatment
with Rapamycin abolished Cdc42-mediated neural lineage specification as well as terminal
neuronal differentiation [98].
MTorc-1 is also implicated in cell proliferation of rat adult hippocampal progenitors that
heavily depend on PI3K-activated Akt-signalling. MTorc-1-dependence is obvious because
presence of Rapamycin interfered with increased cell proliferation under Fgf-2-stimulation.
Although Igf-1 treatment of these cells did not result in increased proliferation, Igf-1 increases
cell division in the presence of Fgf-2 over the rate that is achieved through Fgf-2 alone [99].
Sustained activation of mTor-signalling in mice that are deficient for Tsc-1 results in initially
increased proliferation of NPC and premature depletion of the progenitor pool. Self-renewal
of Tsc-1-deficient and thus mTor-activated NPC is also dramatically impaired. In addition to
increased numbers of cells that differentiate into the neuronal lineage, sustained mTor activity
interferes with terminal differentiation of neurons but seems to promote an increase in
astrocytes [100]. Increased cell proliferation is also a hallmark of Tsc-2-deficient mouse NPC
that are isolated from early (E10.5) developmental time points. This phenotype is also attrib‐
uted to an activation of mTorc-1-signalling [101].
Figure 9. Igf-1-dependent survival of rat hip-pocampal precursors [46].
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Igf-1-initiated survival of E19 rat embryonal hippocampal cells is dependent on PI3K-mediated
Akt-phosphorylation and subsequent phosphorylation of FoxO3. Phosphorylation of FoxO3
is blocked by LY294002 and partially by Rapamycin, and results in increased survival of
hippocampal progenitors. Blocking of MAPK/Erk pathway with PD98059 does not influence
survival of these progenitors [46,102] (Fig. 9).
Figure 10. IIS in regulation of proliferation of adult hippocampal progenitors [77, 78].
Igf-1-mediated proliferation of neural progenitors of the adult DG is mainly but not exclusively
mediated by MAPK/Erk-signalling, since inhibition of MAPKK/Mek-1/2 through a chemical
inhibitor or dominant negative kinases interferes with cell division after Igf-1 treatment.
Blocking of PI3 kinase through LY294002 interferes with proliferation even without addition
of Igf-1. However, blocking of the Akt-downstream signal through use of a dominant negative
kinase also reduces Igf-1-induced mitosis. This finding makes it likely that LY294002-inde‐
pendent activation of Akt might be important for Igf-1-mediated proliferation. Rapamycin
does not have significant effects in this setting, making it likely that mTor-complexes are not
involved in Igf-1-mediated proliferation of adult hippocampal progenitors [77] (Fig. 10).
Further evidence for the implication of Igf-1/MAPK/Erk- signalling in proliferation of adult
hippocampal progenitors comes from the study of increased mitosis after a status epilepticus.
Here, this lesion activates Igf-1-release from microglia. This increase in Igf-1 results in the
activation of the MAPK/Erk-pathway and subsequent cell division. This response is blocked
through inhibition of the Igf-1r as well as through U0129-mediated inhibition of the MAPK-
pathway [78].
It is interesting to point out that the same biological effect can be achieved through Igf-1 by
activating different pathways in different cells: IIS induces proliferation in embryonic rat
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cortical progenitors in an Erk-independent manner, while Igf-1 signalling induces proliferation
of adult hippocampal progenitors via Erk-dependent cytoplasmic downstream signals. On the
other hand, IIS mediates different biological effects in similar cells through similar downstream
molecules, but at different developmental time points: adult hippocampal neurons respond
with proliferation to Igf-1 compared to embryonic hippocampal progenitors that need IIS for
their survival. This summary indicates that we still need comprehensive analyses of overlap‐
ping or distinct target genes activated through overlapping or distinct signalling pathways
during development and in the various cell types of the CNS.
The study of Otaegi et al. of IIS in OBSC also elaborates on downstream signalling by showing
that Igf-1 treatment increases phosphorylation of Akt at Ser473 as well as Thr308 which is
associated with increased proliferation and neural differentiation [54] (Fig. 11). Pten, that
antagonises PI3-kinase induced phosphorylation of phosphatidylinositol (3,4,5)trisphosphate
(PtdIns(3,4,5)P3), reduces basal levels of the activating posttranslational modifications of Akt,
which are however overridden by presence of Insulin/Igf-1. Nevertheless, overexpression of
Pten impaires neural differentiation without affecting progenitor proliferation, and overex‐
pression of a mutant Pten increases OBSC differentiation. Direct inhibition of PI3-kinase
through LY294002 interferes with Igf-1-stimulated Akt-phosphorylation and resultes in
impaired proliferation as well as neural differentiation. Thus, OBSC differentiation is under
control of basic levels of pAkt while increased pAkt-levels through IIS activation affect
additionally proliferation.
Figure 11. IIS affects proliferation and differentiation in adult OBSC [51].
Early postnatal olfactory bulb neurons do survive upon Igf-1-signalling. In this context, a
positive feedback has been proposed between Igf-1 and Bcl-2.  Igf-1 increases expression
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of anti-apoptotic Bcl-2,  and overexpression of Bcl-2 in vivo  results in increased Igf-1 and
Igfbp2 [103].
Figure 12. Survival of CGN upon IIS [90, 104, 105].
Igf-1 action as survival factor for postnatal cerebellar granule neurons (CGN) requires different
intracellular signalling [90]. In this context, Igf-1 activation of PI3K leads to inhibition of Erk
as well as Caspase-3, two pathways exerting different events in cell death, plasma membrane
damage and DNA break-down, respectively. Activated PI3K phosphorylates not only Akt but
also Protein kinase A (PKA). Whereas pAkt activates Caspase-3 and is leading to DNA break-
down, PKA suppresses sustained Erk activation via phosphorylation of cRaf at Ser259 and
prevents plasma membrane damage (Fig. 12).
Further studies of Igf-1-dependent survival of rat CGN links PI3K activation of Akt to
phosphorylation of Bad at Ser136 that is responsible for releasing anti-apoptotic Bcl-XL
[104,105]. This finding is partially corroborated in vivo, where Igf-1 overexpression results in
increased levels of Bcl-XL at early time points (P7) and decreased expression of pro-apoptotic
Bax and Bad at P14 and P21. However, the investigation of the phosphorylation status of Bad
in vivo was not conclusive [92].
Oligodendrogenesis and initiation as well as maintenance of myelination are strongly de‐
pendent on IIS. Several mouse models in which normal IIS was manipulated display pheno‐
types affecting oligodendroglial cells: overexpression of Igf-1 driven by diverse promoters or
administration of Igf-1 into the CSF result in increased numbers of oligodendrocytes and
myelination [106-108], while loss of Igf-1 leads to impaired and lost myelination [109]. IIS in
oligodendrocytes and their precursors is dependent on signalling over the Igf-1r, since Igf-1r-
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deficient mice show retarded growth and initiation of myelination [110]. This phenotype is not
observed in IR-deficient mice and is thus mediated through Igf-1r-signalling [111]. IIS depends
on binding of insulin-response substrate (Irs1-4) to the receptors, which results in their
respective phosphorylation.
Proliferation of oligodendroglial rat precursors increases in response to Igf-1 and is mediated
over a prolonged time period by Pdk-1, Akt Thr308 as well as Ser473 phosphorylation, and
pGsk-3β. Igf-1 treatment also activated the Ras/MAPK-pathway as evidenced by increased
pErk-1/-2, following a fast kinetic over a short period of time [112]. Inhibition of upstream
signalling molecules revealed concerted involvement of PI3K, MAPK as well as Src-kinase in
cell cycle progression, and predominance of Akt-mediated signalling. Although so far ill
defined, cross-talk among the different signalling pathways activated through Igf-1 is a likely
scenario resulting from this study. In continuation of this study it was observed that Igf-1
increases protein synthesis by signalling through PI3K-Akt-mTor-p70S6K-4E-BP1 as well as
by activating Ras/MAPK [113]. Transcription was a prerequisite for mTor-1-dependent protein
synthesis upon Igf-1 in proliferating oligodendroglial precursors. Early differentiation of the
precursors upon Igf-1 also involves transcriptional processes, however subsequent terminal
differentiation is independent. This finding indicates different roles for Igf-1 during oligoden‐
droglial cell development.
Further analyses of these potential downstream signalling components reveal that initiation
of myelination is coupled to the activity of Irs-2 but not to Irs-1. Irs-2-deficient mice display a
defect in timing of myelination and this effect can not be compensated through a simultaneous
upregulation of Igf-1r and Irs-1 expression as well as signalling in these mice [111]. Increased
Igf-1r signalling is shown through increased levels of pAkt, pGsk-3β and pErk-1/2.
Igf-2 influences proliferation of adult DG progenitors [88]. In this study, knockdown of Igf-2
results in decreased mitosis that is paired with reduced phosphorylation of Irs-1 and Akt. This
phenotype is rescued through overexpression of a dominant-active Akt. Blocking of Igf-1r-
signalling reduces proliferation that exceeds the drop observed after Igf-2 knockdown. This
indicates that NPC proliferation in the adult DG is influenced through Igf-1 and Igf-2 ligands
that signal both through the Igf-1r onto Akt.
Signalling of Igf-2 through its cognate Igf-2r has been shown to be important for neuronal
maturation with regard to synapse density and spine morphology [14]. Downstream signals
included the activation of MAPK/Erk- pathway, since changes at the level of the synapses were
inhibited through PD98059.
Igf-2 dependent memory enhancement in adult rat hippocampus requires signalling via the
Igf-2r [13]. This Igf-2 effect is associated with de novo protein synthesis. Further analyses of the
downstream signalling cascade reveales involvement of Gsk-3β, since the Igf-2-specific effect
is blocked by the presence of the Gsk-3β-inhibitor SB216763. It was shown that this cascade
does not act on a widespread cell level but that it mainly regulates molecular events at specific
synapses, e.g. synapses that are "transcriptionally marked" through training. Igf-2 results in
increased synaptic activity as revealed by stable long-term potentiation (LTP). The underlying
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mechanism is therefore deduced to include Igf-2-dependent activation of Gsk-3β that leads to
synaptic mobilisation and expression of the AMPA-receptor GluR1.
Igf-2 is further under control of NF-κB transcription factors. Nuclear import of NF-κB is
prevented by IκB proteins, which are degraded upon activation of the IκB kinase (IKK)
complex. This proteasomal event releases NF-κB into the nucleus. In the adult mouse hippo‐
campus, synaptic IKK/NF-κB signalling is important for function and maturation. Recent data
show that Igf-2 is under control of NF-κB-mediated transcriptional regulation [14]. This study
shows that Igf-2 increases the number of synapses and of mature spines in vitro, while Igf-1
does only have moderate effects in this assay. The Igf-2 effect is predominantly transduced via
the Igf-2r and is prevented through MEK inhibitor PD98059, but not through inhibition of
Gsk-3β or p38 activity. Corroborating these findings in vivo, mice with deficient IKK-2 show
reduced Igf-2 expression and pErk1/2 levels [14].
Igf-2-dependent proliferation of mouse CGP is associated with activation of PI3K, but also
with mTorc-2 activity that is obvious from increased Akt Ser473 phosphorylation [57]. IIS
downstream signalling is followed up to Gsk-3β in this cellular context.
5. Insulin/IGF-signalling cross-talk
5.1. Signalling cross-talk in the central nervous system
In vivo, it is very unlikely that growth factors act alone, but a more likely scenario is the presence
of a plethora of signalling molecules and that a phenotypic consequence is a complicated
interplay of various signalling pathways. Special emphasise is given to know interactions and
cross-talks between such pathways involving IIS, although this is only an emerging field that
awaits further studies.
Cultured NPC from the rat adult SVZ respond with neuronal differentiation upon various
single stimuli, like Fgf-2, Bdnf, Ngf, and Igf-1. When Fgf-2, Bdnf, and Ngf are applied in
combination with Igf-1, significant increases in the number of neurons are observed, indicating
synergistic action upon neuronal differentiation [114]. Another study uses immobilised
growth factors, alone and in different combinations, on which the authors plated NPC from
embryonic rat striatum. Proliferation, neuronal as well as glial differentiation is assessed and
reveals that Igf-1 alone mainly drives neuronal differentiation and does not affect proliferation
or glial differentiation significantly. In combination with Fgf-2, Igf-1 only slightly increases
progenitor states and proliferation, and this effect is even smaller in combination with Egf that
also acts mitotic in single treatments. Bdnf increases neuronal differentiation alone, as does
Igf-1, however the combination of the two factors results in fewer neurons than single
treatments. The differentiation potential of Igf-1 alone is also lowered by presence of the mitotic
growth factors Fgf-2 and Egf. Igf-1 alone does not induce glial differentiation. In combination
with Cntf that induces astrocytic phenotypes alone, Igf-1 decreases Cntf-mediated differen‐
tiation [115].
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The cross-talk of IIS with regard to Fgf-2- as well as Egf-signalling mainly influences stem cell
proliferation, but whether it is synergistically is not yet totally clear [47,49,50,51,52]. A putative
scenario might be that Igf-1 keeps progenitors in a healthy or fit state in which they are ready
for further cell divisions, for which Fgf-2 or Egf are the instructive cues. However, withdrawal
of Fgf-2 is a prerequisite for neuronal differentiation upon Igf-1 presence [85]. Synergistically,
Igf-1-signalling seems to increase the effects of Fgf-2 on NPC proliferation as has been shown
in rat adult hippocampal cells. This effect is dependent on PI3K that is activated upon Fgf-2
treatment [99].
Survival of CNS-derived cells is one of the major and comprehensive effects of IIS in the
developing and adult organism. IIS is only one of several pathways that influence survival,
and thus cross-talk with other pathways might be of principal importance. Bdnf-mediated
signalling is one of such pathways that are studied with regard to IIS. No additive function of
Bdnf- and Igf-1-mediated survival is reported from different cellular sources [102,116],
however other data is contradictory in finding additive affects on prenatal rat hippocampal
cell survival [117] that cumulate on increased pGsk-3β. Consistently reported is a stronger
survival effect under serum-deprivation for IIS compared to Bdnf. The underlying signalling
might again diverge in different cellular systems: hippocampal neurons survive upon Igf-1
and Bdnf through induction of the PI3K-pAkt branch and survival is blocked by LY294002.
Activity of the MAPK-pErk1/2 branch does not mediate survival. However, cortical neurons
that also depend much stronger on IIS than on Bdnf-signalling for their survival also activate
the PI3K-pAkt branch [117], but LY294002 does not completely attribute for survival upon IIS.
In addition, Src-kinase is activated in these cortical neurons upon Igf-1, corroborating the
finding of an involvement of Pac1-r-signalling in IIS-mediated survival in cortical neurons [91].
Nevertheless, Bdnf and IIS have additive effects in the activation of PI3-K, although this is not
detectable on the level of the number of surviving cells. This finding strongly suggests that IIS
is overriding the effects of Bdnf in survival of CNS-derived cells. However, one Bdnf effect on
hippocampal as well as cortical neurons is to slightly activate Irs-1 and -2 phosphorylation,
indicating a potential cross-activation of IIS through Bdnf. Whether this cross-activation is of
physiological significance in the presence of Igf-1, remains to be determined.
Studies of neural cell proliferation provide evidence of IIS cross-talk with the Wnt/β-catenin
pathway. Nestin-expressing neural progenitors as well as oligodendrocytes express different
levels of β-catenin upon Igf-1 deletion or treatment [118,119]. In vitro, Igf-1 induces increase of
β-catenin as well as CycD1 expression in a PI3K-Akt kinases dependent manner in cultured
oligodendrocytes. β-catenin is also known to activate CycD1 and thus defines a point of
intersection between IIS and Wnt signalling [118]. Impaired proliferation of NPCs is observed
after inactivation of the Igf-1r in Nestin-positive cells. Such NPCs of prenatal mouse brains are
dependent on Wnt-signalling when proliferating, and Igf-1r inactivation results in decreased
levels of Gsk-3β and β-catenin, but with increased levels of the Wnt-receptor Frizzeled3 and
Wnt3a. While the former expression changes are influenced through the Igf-1/PI3K/Akt-
pathway, increased levels of Frizzeled3 and Wnt3a are thought to reflect a compensatory
regulation stimulated by low levels of β-catenin. Inactivation of Gsk-3β in this setting reverts
β-catenin levels and overcomes the block of proliferation as consequence of Igf-1r inactivation.
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Overexpression of Igf-1 increases β-catenin-levels and stimulates progenitor proliferation
[119]. These experiments clearly establish an important cross-talk to regulate progenitor
proliferation in the developing brain.
IIS has also been described to cross-talk with the Tgfβ-pathway in numerous systems [120].
However, a comprehensive analysis of the multiple points of intersections was not published
yet for the nervous system. In a general view, Tgfβ-ligands 1, 2, and 3 exert opposing effects
compared to IIS. This has been shown for the potential of NPC proliferation and differentiation
[121] upon Tgfβ-treatment, since these cells stop proliferating and initiate neuronal differen‐
tiation in mouse E16.5 hippocampus and cerebral cortex, in vitro and in vivo. Proliferation and
differentiation of ESCs are also influenced in opposite ways through IIS or Tgfβ-signalling.
Smad4-deficient ESC show increased neuronal differentiation, and hereby preferentially in
neuronal lineages of the mid- and anterior hindbrain [122]. Further, more serotonergic neurons
of the dorsal midbrain are observed in in vitro differentiated Smad4-deficient cultures.
However, Smad4 is a transcriptional mediator of several members of the Tgfβ-superfamiliy,
including Activin-, Gdf-, Nodal-, Tgfβ- as well as Bmp-signalling. Thus, direct correlation to
one specific signalling pathway is not achieved in this study. Neural induction of human ESCs
is also increased in the presence of the Alk4,5,7 inhibitor SB431542 that interferes with Activin-,
Gdf- and Nodal-signalling apart from Tgfβ. Increased differentiation into the neural lineage
is assessed by Pax-6 expression which is accompanied by decreased Bmp-4 and increased
Noggin expression. These dynamics point to a contribution of several members of the Tgfβ-
superfamily of which the Bmp branch has a major contribution [123], but certainly does not
act alone. Of further note, neuronal differentiation of ESC cells is not solely dependent on
signalling of the above mentioned members of the Tgfβ-superfamily, since deletion of the
common effector Smad4 in ESC does not completely abolish the potential for neuronal
differentiation [122]. In contrast, IIS keeps ESCs in a proliferative state and is necessary for self-
renewal. Whether both pathways cross-talk to suppress the respective other one is not
investigated so far, but might be a likely scenario, given the connections described in other
cellular lineages.
FoxO and Smad proteins interact and the FoxO/Smad complex is implicated in transcriptional
control in early mouse cortical NPCs, thereby defining one point of intersection of IIS and
Tgfβ. Smad2 and 3 transcriptions factors are part of the canonical Tgfβ-signalling pathway and
are phosphorylated upon binding of Tgfβ-ligands to the Tgfβ-receptor 1 and 2. The phos‐
phorylated proteins bind to Smad4 and together translocate to the nucleus. This Smad complex
interacts with FoxO1, 3a, and 4, three TF of the forkhead family that are under influence of IIS.
Upon activation of the Igf-1r, FoxO TF are phosphorylated in a PI3K-Akt-dependent manner.
This phosphorylation leads to retention of FoxO proteins in the cytoplasm. Thus, IIS opposes
transcriptional control through the Tgfβ-pathway by interfering with translocation of cofactors
into the nucleus [124].
While survival of cerebellar granule precursors depends on IIS, control of CGP proliferation
indicates cross-talk of IIS and Shh-signalling [34,55,125]. Igf/Shh interaction is reported to occur
on various levels. The study of Fernandez et al. (2010) suggests that IIS via Igf-1r increases Shh-
mediated proliferation, but IIS-mediated proliferation is independent on Shh-signalling. In
Trends in Cell Signaling Pathways in Neuronal Fate Decision60
this setting, Igfbp-5 interfered with Shh-mediated cell proliferation. Igf-2-signalling increases
levels of Gli-1, a transcription factor that is mainly activated through Shh-signalling. Gli-1 as
well as Gsk-3β are regulators of CycD1, which might be another point of intersection between
these two signalling pathways besides regulation of Shh-target Nmyc-1 through Gsk-3β
[57,126]. Parathath and colleagues established a role for Irs-1 and mTorc-1 upon Shh-mediated
CGP proliferation. This study shows specific upregulation of Irs-1 protein upon Shh that does
not result in the activation of Akt. Knockdown of Irs-1 abolishes Shh-mediated CGP prolifer‐
ation, which is in turn activated upon Irs-1 overexpression. Irs-1 overexpression increases or
maintains expression levels of CycD2 and Nmyc-1, which are implicated in cell cycle control.
Irs-1 protein stability in CGP is controlled by the negative feed back loop, in which mTorc-1-
activation induces p70S6K that phosphorylates Irs-1 and targets Irs-1 for degradation. Shh-
dependent increase in Irs-1 is dependent on mTorc-1-inhibition that is followed by suppression
of p70S6K-kinase activity [125]. In contrast to this study, Hartmann et al. [57] postulated PI3K/
Akt- and synergistically Shh-dependent transcriptional control of Gli-1 and CycD1 as possible
lines of interaction.
Although these data corroborate tight connections between Shh and IIS, there is need for
further mechanistic investigation to define further knots in the signalling network.
6. Concluding remarks
As pointed out through the many studies of IIS in the CNS, this signalling pathway has an
essential role for development and function of this organ. Albeit studied in many laboratories,
our understanding of this central signalling pathway is far from being complete. Still we do
not understand how the same biological function is achieved by activating different down‐
stream cascades and why it is necessary to have these multiple pathways that respond to one
stimulus. We also do not know why different biological functions are the consequence of IIS
at different developmental time points in cells from the same part of the brain. In this light it
is of major interest that studies are emerging that focus on cross-talks of various stimuli.
Exposure to multiple stimuli at a time probably reflects more the natural environment of a
developing and mature neural cell than exposure to one single growth factor. It is also of major
interest to dissect different functions during development and to define the molecular players
involved into functional switches. In this regard it will be important to dissect different
subcomplexes of PI3Ks or Akts that might be implicated in IIS. It will be also needed to carefully
analyse the balances between the different branches of the signalling cascades and to identify
and close further gaps that might be still in the pathways as they are commonly described
today. Given the central role of IIS in body development, growth and maintenance, this
knowledge will be of utmost interest and will also be exploited for therapeutic medicine in
various contexts.




CA - Cornu ammonis, CGN - Cerebellar granule neurons, CGP - Cerebellar granule precursor,
CNS - Central nervous system, CSF - Cerebrospinal fluid, DG - dentate gyrus, ESC - Embryonic
Stem Cell, GH - Growth hormone, IIS - Insulin/Igf-signalling, Igf - Insulin like growth factor
1, Igfbp - Insulin like growth factor binding protein, Ir - Insulin receptor, mTOR - mammalian
target of rapamycin, NSC - Neural Stem Cell, NPC - Neural Progenitor cell, OB - Olfactory
Bulb, OBSC - Olfactory Bulb stem cell, p - phospho-, SGZ - Subgranular zone, SVZ - Subven‐
tricular zone, TF - Transcription factor.
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